Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 2
2005 4
2006 4
2007 8
2008 8
2009 4
2011 3
2012 7
2013 4
2014 1
2015 5
2016 5
2017 1
2018 3
2019 1
2020 8
2021 10
2022 5
2023 2
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

79 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Unsever
Page 1
The effect of virtual reality on pain, fear, and anxiety during access of a port with huber needle in pediatric hematology-oncology patients: Randomized controlled trial.
Gerçeker GÖ, Bektaş M, Aydınok Y, Ören H, Ellidokuz H, Olgun N. Gerçeker GÖ, et al. Eur J Oncol Nurs. 2021 Feb;50:101886. doi: 10.1016/j.ejon.2020.101886. Epub 2020 Dec 1. Eur J Oncol Nurs. 2021. PMID: 33321461 Clinical Trial.
Before and after the port needle insertion procedure, anxiety and fear assessed using self- and parent-report using the Children's Anxiety Meter and Child Fear Scale. The primary outcome was the patient-reported pain scores after the procedure and fear and anxiety scores b …
Before and after the port needle insertion procedure, anxiety and fear assessed using self- and parent-report using the Children's An …
Thalassemia.
Aydinok Y. Aydinok Y. Hematology. 2012 Apr;17 Suppl 1:S28-31. doi: 10.1179/102453312X13336169155295. Hematology. 2012. PMID: 22507773
Final Results of RIGHT Choice: Ribociclib Plus Endocrine Therapy Versus Combination Chemotherapy in Premenopausal Women With Clinically Aggressive Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer.
Lu YS, Mahidin EIBM, Azim H, Eralp Y, Yap YS, Im SA, Rihani J, Gokmen E, El Bastawisy A, Karadurmus N, Lim YN, Lim CS, Duc LT, Chung WP, Babu KG, Penkov K, Bowles J, Alfaro TD, Wu J, Gao M, Slimane K, El Saghir NS. Lu YS, et al. J Clin Oncol. 2024 Aug 10;42(23):2812-2821. doi: 10.1200/JCO.24.00144. Epub 2024 May 21. J Clin Oncol. 2024. PMID: 38771995 Free PMC article. Clinical Trial.
METHODS: In this open-label, multicenter, randomized phase II trial, pre/perimenopausal women with clinically aggressive HR+/HER2- ABC were randomly assigned 1:1 to first-line ribociclib (600 mg once daily; 3 weeks on, 1 week off) plus letrozole/anastrozole and goserelin or inves …
METHODS: In this open-label, multicenter, randomized phase II trial, pre/perimenopausal women with clinically aggressive HR+/HER2- ABC were …
Infliximab for vascular involvement in Behcet's syndrome.
Hatemi G, Tukek NB, Esatoglu SN, Ozguler Y, Taflan SS, Uygunoglu U, Melikoglu M, Ugurlu S, Fresko I, Siva A, Kutlubay Z, Yurdakul S, Yazici H, Hamuryudan V. Hatemi G, et al. Clin Immunol. 2023 Aug;253:109682. doi: 10.1016/j.clim.2023.109682. Epub 2023 Jun 28. Clin Immunol. 2023. PMID: 37385325
OBJECTIVE: Vascular involvement is an important cause of morbidity and mortality in patients with Behcet's syndrome (BS). We aimed to survey the efficacy and safety of infliximab (IFX) in BS patients with vascular involvement followed in a dedicated tertiary center. ...
OBJECTIVE: Vascular involvement is an important cause of morbidity and mortality in patients with Behcet's syndrome (BS). We aimed to …
Iron Chelation Therapy as a Modality of Management.
Aydinok Y. Aydinok Y. Hematol Oncol Clin North Am. 2018 Apr;32(2):261-275. doi: 10.1016/j.hoc.2017.12.002. Epub 2018 Jan 17. Hematol Oncol Clin North Am. 2018. PMID: 29458731 Review.
Updated approach for the management of osteoporosis in Turkey: a consensus report.
Kirazlı Y, Atamaz Çalış F, El Ö, Gökçe Kutsal Y, Peker Ö, Sindel D, Tuzun Ş, Gogas Yavuz D, Durmaz B, Akarirmak Ü, Bodur H, Hamuryudan V, Inceboz U, Öncel S. Kirazlı Y, et al. Arch Osteoporos. 2020 Aug 29;15(1):137. doi: 10.1007/s11657-020-00799-0. Arch Osteoporos. 2020. PMID: 32860546 Free PMC article. Review.
Building a Sustainable Comprehensive Multiple Myeloma Program in Western Kenya.
Oduor MA, Lotodo TC, Vik TA, Manyega KM, Loehrer P, Omondi AA, Oguda JO, Asirwa FC. Oduor MA, et al. JCO Glob Oncol. 2021 Mar;7:400-407. doi: 10.1200/GO.20.00572. JCO Glob Oncol. 2021. PMID: 33739854 Free PMC article.
To improve outcomes of patients with MM in Western Kenya, the Academic Model Providing Access to Healthcare (AMPATH) MM Program was set up in 2012. In this article, the program's activities, challenges, and future plans are described distilling important lessons that can b …
To improve outcomes of patients with MM in Western Kenya, the Academic Model Providing Access to Healthcare (AMPATH) MM Program was set up i …
Mitochondrial Mutations in Multiple Sclerosis Patients with Atypical Optic Neuropathy.
Beckmann Y, Uzunköprü C, Subaşıoğlu A. Beckmann Y, et al. Mult Scler Relat Disord. 2021 Oct;55:103166. doi: 10.1016/j.msard.2021.103166. Epub 2021 Jul 25. Mult Scler Relat Disord. 2021. PMID: 34333271
We strongly recommend investigating Leber's hereditary optic neuropathy mutations in MS patients if they suffer from severe or bilateral visual loss without recovery during follow-up. Because Leber's hereditary optic neuropathy mitochondrial mutations indicate relat …
We strongly recommend investigating Leber's hereditary optic neuropathy mutations in MS patients if they suffer from severe or bilate …
Urinary tract infections in the geriatric patients.
Alpay Y, Aykin N, Korkmaz P, Gulduren HM, Caglan FC. Alpay Y, et al. Pak J Med Sci. 2018 Jan-Feb;34(1):67-72. doi: 10.12669/pjms.341.14013. Pak J Med Sci. 2018. PMID: 29643881 Free PMC article.
The laboratory values for CRP, ESR and leukocyte count were 84 mg/dL, 56 mm/s and 11.9 (10^3muL), with mean values being determined. Among patients having a urinary catheter (17.1%), 27.9% had a history of UTI, while 29.3% had been hospitalised. ...
The laboratory values for CRP, ESR and leukocyte count were 84 mg/dL, 56 mm/s and 11.9 (10^3muL), with mean values being determined. …
79 results